Role of interferon-gamma in lung inflammation following cecal ligation and puncture in rats

Shock

Volumn 12, Issue 3, 1999, Pages 215-221

  Yin, Kingsley ^a   Hock, Carl E ^a   Lai, Pi Shiang ^a   Ross, Jason T ^a   Yue, Gang ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; NITRITE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; CECUM; IMMUNOHISTOCHEMISTRY; LIGATION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PNEUMONIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; CECUM; CONSTRICTION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; MALE; NITRITES; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033190889     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199909000-00008     Document Type: Article

References (35)

1. Young HA, Hardy, KJ: Interferon γ: Producer cells, activation stimuli, and molecular genetic regulation. Pharmacol Ther 45:137-151, 1990.
2. Le J, Lin JX, Henriksen-Destefano D, Vilcek J: Bacterial lipopolysaccharide-induced interferon y production:roles of interleukin-1 and interleukin-2. J Immunol 136:4525-4530, 1988.
3. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA: Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor. J Immunol 149:1666-1670, 1992.
4. Keller R, Joller P, Keist R, Binz H, van der Meide PH: Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Scand J Immunol 28:113-121, 1988.
5. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon γ as the lymphokine that activates human macrophage oxidative metabolism and anti-microbial activity. J Exp Med 158:670-689, 1983.
6. Torrico F, Heremans H, Rivera, MT, Van Marck E, Billiau A, Carlier Y: Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146:3626-3632, 1991.
7. Evans T, Carpenter A, Silva A, Cohen J: Differential effects of monoclonal antibodies to tumor necrosis factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram-negative sepsis. Infect Immun 60:4133-4139, 1992.
8. Hock CE, Yin K, Yue G, Wong PY-K: Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia. Am J Physiol 272:H843-850, 1997.
9. Miles RH, Paxton TP, Dries DJ, Gamelli RL: Interferon-gamma increases mortality following cecal ligation and puncture. J Trauma 36:607-611, 1994.
10. Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P, Heumann D, Aguet M, Ryffel B: Interferon-gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 179:1437-1444, 1994.
11. Yin K, Hock CE, Tahamont M, Wong PY-K: Time-dependent cardiovas-cular and inflammatory changes in acute endotoxemia. Shock 9:434-442, 1998.
12. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (IL-1, 11-6 and TNF). Circ Shock 36:191-199, 1992.
13. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH: Role of interleukin-6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg 128:89-94, 1993.
14. Ayala A, O'Neill PJ, Uebele SA, Herdon CD, Chaudry IH: Mechanism of splenic immunosuppression during sepsis: Key role of Kupffer cell mediators. J Trauma 42: 882-888, 1997.
15. Wichterman, KA, Baue, AE, Chaudry, IH: Sepsis and septic shock: A review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
16. Mercer-Jones MA, Heinzelman M, Peyton JC, Wickel D, Cook M, Cheadle WG: The pulmonary inflammatory response to experimental fecal peritonitis: Relative roles of tumor necrosis factor-α and endotoxin. Inflammation 21:401-417, 1997.
17. Vromen A, Arkovitz MS, Zingarelli B, Salzman AL, Garcia VF, Szabo C: Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 6:248-253, 1996.
18. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery 85:205-211, 1979.
19. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD: A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunological Methods 177:23-28, 1994.
20. Wilder JA, Yuan D: Regulation of IFN-γ mRNA in murine natural killer cells, Int Immunol 7:575-582, 1995.
21. Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner J-D, Glauser MP: IFN-γ involvement in the severity of Gram-negative infections in mice. J Immunol 151:916-921, 1993.
22. Cross AR, Jones OTG: Enzymatic mechanisms of superoxide production. Biochim Biophys Acta 1057:291-298, 1991.
23. Zisman DA, Kunkel SL, Strieter RM, Gauldie J, Tsai WC, Bramson J, Wilkowski JM, Bucknell KA, Sandiford TJ: Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349-356, 1997.
24. Abe M, Goya T, Mitsuyama T, Torisu M, Furukawa, T: Evaluation of the effects of steroids on experimental septic lung injury. Prost Leuk & Essent Fatty Acids 54:123-128, 1996.
25. Davreux CJ, Soric I, Nathens AB, Watson RWG, McGivray ID, Suntres Z, Shek PN, Rotstein OD: N-acetyl cysteine attenuates acute lung injury in the rat. Shock 8:432-438, 1997.
26. Suter PM, Domenighetti G, Schaller M-D, Laverriere MC, Ritz R, Perret C: N-acetylcysteine enhances recovery from acute lung injury in man. Chest 105:190-194, 1994.
27. Liu P, Yin K, Nagele R, Wong PY-K: Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 284:1139-1146, 1998.
28. Sprague RS, Stephenson AH, McMurdo L, Lonigro AJ: Nitric oxide opposes phorbol ester-induced increases in pulmonary microvascular perme-ability in dogs. J Pharmacol Exp Ther 284:443-448, 1998.
29. Wray GM, Millar CG, Hinds CJ, Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 9:329-335, 1998.
30. Unno N, Menconi MJ, Smith M, Fink MP: Nitric oxide mediates interferon γ-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 23:1170-1176, 1995.
31. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury. Shock 7:235-246, 1996.
32. Szabo C, Bay BJ, Salzman AL: Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages, using a novel mesopophyrin superoxide dismutase analog and peroxynitrite scavenger. FEBS Lett 381: 82-86, 1996.
33. Le Roy D, Heumann D, Glauser M-P, Mauel J, Smith J, Corradin SB: Nitric oxide production in experimental gram-negative infection: Studies with cytokine receptor-deficient mice. Shock 10:37-42, 1998.
34. Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, Heidecke CD, Pfeffer K: Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infection & Immunity 66:2300-2309, 1998.
35. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste-Amezaga M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trichieri G: Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med 176: 1387-1398, 1992.